Inovio Pharmaceuticals Inc. (NASDAQ: INO)
$11.10
-0.0300 ( -0.27% ) 170.6K
Inovio Pharmaceuticals Inc is a United States-based biotechnology company that develops active DNA-based immunotherapies and vaccines to treat and prevent cancers and infectious diseases. The company is engaged in gene therapy, where its immunotherapy platform consists of DNA-based immunotherapy and electroporation delivery technologies.
Market Data
Open
$11.10
Previous close
$11.13
Volume
170.6K
Market cap
$287.09M
Day range
$10.71 - $11.32
52 week range
$3.89 - $14.75
SEC Fillings
| Form Type | Description | Pages | Date |
|---|---|---|---|
| 4 | Insider transactions | 1 | Feb 28, 2024 |
| 4 | Insider transactions | 1 | Feb 28, 2024 |
| 4 | Insider transactions | 1 | Feb 28, 2024 |
| 8-k | 8K-related | 13 | Jan 25, 2024 |
| 8-k | 8K-related | 12 | Jan 12, 2024 |
| def | Proxies and info statements | 4 | Nov 28, 2023 |
| pre | Proxies and info statements | 3 | Nov 17, 2023 |
| 8-k | 8K-related | 13 | Nov 09, 2023 |
| 10-q | Quarterly Reports | 74 | Nov 09, 2023 |
| 8-k | 8K-related | 12 | Nov 02, 2023 |